Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FibroGen
Biotech
Prostate cancer ADC breaks FibroGen's clinical losing streak
FibroGen had a run of bad luck last year, but phase 1 data posted this week suggest its earlier-stage pipeline still has potential.
James Waldron
Apr 3, 2024 10:55am
Another Biogen exec hitches ride to Voyager —Chutes & Ladders
Mar 15, 2024 9:30am
FibroGen fails in DMD, continuing rotten run of phase 3 flops
Aug 30, 2023 5:54am
Pfizer exec out the door—Chutes & Ladders
Jul 28, 2023 9:30am
FibroGen lays off 104 employees while ImmuneID restructures
Jul 19, 2023 12:27pm
Another clinical failure sends FibroGen hunting for cost savings
Jun 26, 2023 9:42am